# MYDAYIS

NDC: 54092-474
Generic name: DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, and AMPHETAMINE SULFATE
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20170620

FDA application: NDA022063

## Active ingredients

- AMPHETAMINE ASPARTATE MONOHYDRATE: 9.375 mg/1
- AMPHETAMINE SULFATE: 9.375 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 9.375 mg/1
- DEXTROAMPHETAMINE SULFATE: 9.375 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54092-474"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54092-474
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=141a7970-3f06-44ea-9ab7-aeece2c085fc